相关实验视频
Updated: May 9, 2026

08:58
Murine Kidney Transplant Technique
Published on: October 20, 2015
16.1K
寒冷缺血时间和脏捐赠者概况指数之间的相互作用对后移植结果的影响
Winn T Cashion1, Xingyu Zhang2, Chethan Puttarajappa3
1Department of Medicine, Division of Nephrology, Maine Health, Portland, ME, USA.
概括
高脏捐赠者概况指数 (KDPI) 和长冷缺血时间 (CIT) 独立地恶化脏移植结果. 它们的相互作用会对短期的移植功能产生影响,特别是在KDPI下部的脏.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植手术 移植手术
- 免疫学 免疫学 免疫学
背景情况:
- 脏捐赠者概况指数 (KDPI) 和感冒缺血时间 (CIT) 是影响脏移植 (KT) 成功的关键因素.
- 了解KDPI和CIT之间的相互作用对于优化捐赠器官利用和受体结果至关重要.
研究的目的:
- 调查KDPI和CIT在各种后KT结果上的相互作用.
- 为了确定KDPI和CIT的综合效应是否不同于它们的单个效应.
主要方法:
- 在美国 (2014-2020年) 对成年已故捐赠者KT接受者的分析.
- 分层为KDPI组 (≤20%, 21%-85%, >85%) 和CIT层 (<12, 12-17.9, 18-23.9, ≥24小时).
- 多变量分析以评估对初级移植不功能 (PGNF),延迟移植功能 (DGF),eGFR,患者存活率,移植存活率和死亡审查的移植存活率 (DCGS) 的相互作用影响.
主要成果:
- 增加KDPI和CIT与较差的KT结果有关.
- 在PGNF,DGF和6个月的eGFR中观察到KDPI和CIT之间的显著相互作用.
- 与高KDPI移植相比,较低和中等KDPI移植中,较长CIT的有害影响更为明显.
- 在死亡率,移植存活率或DCGS方面没有发现显著的相互作用.
结论:
- 高KDPI和长时间的CIT是KT不良结果的独立风险因素.
- KDPI和CIT之间的相互作用显著影响短期结果,对KDPI下部脏的影响更大.
- 这些发现强调了在器官分配和管理中考虑供体质量和保存时间的重要性.
相关概念视频
Blood Transfusion and Agglutination
13.2K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
13.2K
Blood Transfusion
3.0K
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
3.0K
Bone Marrow Sampling and Transplants
3.1K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.1K
Tissue Transplantation
1.4K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
Kidney Transplant I: Introduction
850
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
850

